Tryp Therapeutics Performance
| TRYPFDelisted Stock | USD 0.05 0 6.89% |
The entity has a beta of 0.58, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Tryp Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Tryp Therapeutics is expected to be smaller as well. Tryp Therapeutics right now has a risk of 0.0%. Please validate Tryp Therapeutics expected short fall, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Tryp Therapeutics will be following its existing price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Tryp Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Tryp Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 3.7 M |
Tryp |
Tryp Therapeutics Relative Risk vs. Return Landscape
If you would invest 5.00 in Tryp Therapeutics on September 3, 2024 and sell it today you would earn a total of 0.00 from holding Tryp Therapeutics or generate 0.0% return on investment over 90 days. Tryp Therapeutics is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded otc stocks are less volatile than Tryp, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Tryp Therapeutics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tryp Therapeutics' investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Tryp Therapeutics, and traders can use it to determine the average amount a Tryp Therapeutics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| TRYPF |
Based on monthly moving average Tryp Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tryp Therapeutics by adding Tryp Therapeutics to a well-diversified portfolio.
Tryp Therapeutics Fundamentals Growth
Tryp OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Tryp Therapeutics, and Tryp Therapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Tryp OTC Stock performance.
| Return On Equity | -9.22 | |||
| Return On Asset | -2.05 | |||
| Current Valuation | 4.17 M | |||
| Shares Outstanding | 96.42 M | |||
| Price To Book | 2.50 X | |||
| EBITDA | (7.36 M) | |||
| Cash And Equivalents | 2.85 M | |||
| Cash Per Share | 0.03 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (5.81 M) | |||
| Earnings Per Share | (0.13) X | |||
| Total Asset | 2.34 M | |||
About Tryp Therapeutics Performance
By analyzing Tryp Therapeutics' fundamental ratios, stakeholders can gain valuable insights into Tryp Therapeutics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Tryp Therapeutics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Tryp Therapeutics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Tryp Therapeutics Inc., a pharmaceutical company, focuses on identifying and developing compounds for diseases with high unmet medical needs. The company was incorporated in 2019 and is based in Kelowna, Canada. Tryp Thrapeutics operates under Biotechnology classification in the United States and is traded on OTC Exchange.Things to note about Tryp Therapeutics performance evaluation
Checking the ongoing alerts about Tryp Therapeutics for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Tryp Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Tryp Therapeutics is not yet fully synchronised with the market data | |
| Tryp Therapeutics has some characteristics of a very speculative penny stock | |
| Tryp Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (7.49 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Tryp Therapeutics has accumulated about 2.85 M in cash with (5.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03. | |
| Roughly 47.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Tryp Therapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Tryp Therapeutics' stock is overvalued or undervalued compared to its peers.
- Examining Tryp Therapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Tryp Therapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Tryp Therapeutics' management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Tryp Therapeutics' otc stock. These opinions can provide insight into Tryp Therapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Tryp OTC Stock
If you are still planning to invest in Tryp Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tryp Therapeutics' history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |